206 related articles for article (PubMed ID: 19441788)
1. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets.
Mechref Y; Hussein A; Bekesova S; Pungpapong V; Zhang M; Dobrolecki LE; Hickey RJ; Hammoud ZT; Novotny MV
J Proteome Res; 2009 Jun; 8(6):2656-66. PubMed ID: 19441788
[TBL] [Abstract][Full Text] [Related]
2. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
3. Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry.
Hu Y; Desantos-Garcia JL; Mechref Y
Rapid Commun Mass Spectrom; 2013 Apr; 27(8):865-77. PubMed ID: 23495056
[TBL] [Abstract][Full Text] [Related]
4. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus.
Shah AK; Hartel G; Brown I; Winterford C; Na R; Cao KL; Spicer BA; Dunstone MA; Phillips WA; Lord RV; Barbour AP; Watson DI; Joshi V; Whiteman DC; Hill MM
Mol Cell Proteomics; 2018 Dec; 17(12):2324-2334. PubMed ID: 30097534
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
7. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1.
Karamchandani DM; Lehman HL; Ohanessian SE; Massé J; Welsh PA; Odze RD; Goldblum JR; Berg AS; Stairs DB
Diagn Pathol; 2016 Feb; 11():23. PubMed ID: 26926447
[TBL] [Abstract][Full Text] [Related]
8. Ion mobility-mass spectrometry analysis of serum N-linked glycans from esophageal adenocarcinoma phenotypes.
Gaye MM; Valentine SJ; Hu Y; Mirjankar N; Hammoud ZT; Mechref Y; Lavine BK; Clemmer DE
J Proteome Res; 2012 Dec; 11(12):6102-10. PubMed ID: 23126309
[TBL] [Abstract][Full Text] [Related]
9. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
10. Quantitative LC-MS/MS Glycomic Analysis of Biological Samples Using AminoxyTMT.
Zhou S; Hu Y; Veillon L; Snovida SI; Rogers JC; Saba J; Mechref Y
Anal Chem; 2016 Aug; 88(15):7515-22. PubMed ID: 27377957
[TBL] [Abstract][Full Text] [Related]
11. Glycomic analysis using glycoprotein immobilization for glycan extraction.
Yang S; Li Y; Shah P; Zhang H
Anal Chem; 2013 Jun; 85(11):5555-61. PubMed ID: 23688297
[TBL] [Abstract][Full Text] [Related]
12. A serum glycomics approach to breast cancer biomarkers.
Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of CD44 and DKK1 in the progression of Barrett's esophagus to esophageal adenocarcinoma.
Darlavoix T; Seelentag W; Yan P; Bachmann A; Bosman FT
Virchows Arch; 2009 Jun; 454(6):629-37. PubMed ID: 19396460
[TBL] [Abstract][Full Text] [Related]
15. Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
Hamilton JP; Sato F; Jin Z; Greenwald BD; Ito T; Mori Y; Paun BC; Kan T; Cheng Y; Wang S; Yang J; Abraham JM; Meltzer SJ
Clin Cancer Res; 2006 Nov; 12(22):6637-42. PubMed ID: 17121882
[TBL] [Abstract][Full Text] [Related]
16. The Aristotle Classifier: Using the Whole Glycomic Profile To Indicate a Disease State.
Hua D; Patabandige MW; Go EP; Desaire H
Anal Chem; 2019 Sep; 91(17):11070-11077. PubMed ID: 31407893
[TBL] [Abstract][Full Text] [Related]
17. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.
Chiam K; Wang T; Watson DI; Mayne GC; Irvine TS; Bright T; Smith L; White IA; Bowen JM; Keefe D; Thompson SK; Jones ME; Hussey DJ
J Gastrointest Surg; 2015 Jul; 19(7):1208-15. PubMed ID: 25943911
[TBL] [Abstract][Full Text] [Related]
18. Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer.
Kudelka MR; Lasanajak Y; Smith DF; Song X; Hossain MS; Owonikoko TK
Cancer Med; 2023 Mar; 12(6):6768-6777. PubMed ID: 36437732
[TBL] [Abstract][Full Text] [Related]
19. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
